Atlas Trials

Lung Cancer, Small Cell

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lung Cancer, Small Cell

RecordFirmDate
Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer (NCT05320458)Hasan Kalyoncu University2022-05-02
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC (NCT05228496)Zhejiang Cancer Hospital2022-03-17
Trial of NanoPac Intratumoral Injection in Lung Cancer (NCT04314895)NanOlogy, LLC2021-04-14
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929)Carisma Therapeutics Inc2021-02-02
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer (NCT04986670)Tufts University2020-11-24
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment (NCT04440800)Royal Marsden NHS Foundation Trust2020-07-01
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA (NCT03499678)HKGepitherapeutics2018-07-01
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population (NCT01313663)GlaxoSmithKline2011-02-01
Regulatory Hycamtin(Oral) PMS (NCT01037023)GlaxoSmithKline2010-10-01
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome (NCT00997061)GlaxoSmithKline2009-11-01
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer (NCT00698516)GlaxoSmithKline2008-07-01
First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin (NCT00316186)GlaxoSmithKline2005-06-01
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors (NCT00259935)GlaxoSmithKline2004-10-04
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) (NCT00043862)GlaxoSmithKline2002-08-01
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer (NCT00320359)GlaxoSmithKline2002-08-01
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors (NCT00046111)GlaxoSmithKline2001-09-01
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer (NCT00276276)GlaxoSmithKline2000-11-01

Track Lung Cancer, Small Cell automatically

Every clearance here is in the API, with alerts when new ones post.